Patent Assignment
Reel/Frame 047037/0294
Assignment of Assignor's Interest
Recorded: 2018-10-02
Pages: 7
Assignor
ANDERSON, DAVID RANDOLPH
Executed: 2018-09-28
Assignee
ACLARIS THERAPEUTICS, INC.
640 LEE ROAD, SUITE 200, WAYNE, PENNSYLVANIA, 19087
Covered Properties
(2)
Pyrrolopyrimidine Itk Inhibitors for Treating Inflammation and Cancer
Patent:
10,316,038 →
Application:
15/880,385 →
Publication:
US 2018/0208594
PCT:
PCT/US2018/015320 ↗
Pyrrolopyrimidine Itk Inhibitors for Treating Inflammation and Cancer
Application:
62/450,450 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Nov 16, 2017
From: CONFLUENCE LIFE SCIENCES, INC.
To: ACLARIS LIFE SCIENCES, INC.
Reel/Frame 044477/0208 →
Assignment of Assignor's Interest
May 15, 2018
From: ACLARIS LIFE SCIENCES, INC.
To: ACLARIS THERAPEUTICS, INC.
Reel/Frame 046153/0695 →
Assignment of Assignor's Interest
Jul 26, 2018
From: JACOBSEN, ERIC JON; BLINN, JAMES ROBERT; HOCKERMAN, SUSAN LANDIS; SPRINGER, JOHN ROBERT
To: ACLARIS THERAPEUTICS, INC.
Reel/Frame 046471/0721 →